Home › Funds › WEYBOSSET RESEARCH & MANAGEMENT LLC › LH
WEYBOSSET RESEARCH & MANAGEMENT LLC position in LH
LABCORP HOLDINGS INC · Health Care
WEYBOSSET RESEARCH & MANAGEMENT LLC reported holding 39,653 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 3.52% of its reported portfolio and ranking #14 among its reported holdings. WEYBOSSET RESEARCH & MANAGEMENT LLC has disclosed LH holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How WEYBOSSET RESEARCH & MANAGEMENT LLC's LH position evolved
WEYBOSSET RESEARCH & MANAGEMENT LLC first disclosed a stake in LH in Q3 2023 at 39,538 shares (US$7.9M). The position peaked in Q3 2026 at 39,653 shares, worth US$12.2M. Across 12 filings, WEYBOSSET RESEARCH & MANAGEMENT LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 39,653 shares valued at US$12.2M — an increase of 214 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 39.54K | $7.95M | New |
| Q4 2023 | 39.76K | $9.04M | Add |
| Q1 2024 | 39.15K | $233.00K | Reduce |
| Q3 2024 | 39.45K | $8.82M | New |
| Q4 2024 | 39.42K | $9.04M | Hold |
| Q1 2025 | 39.20K | $9.12M | Reduce |
| Q2 2025 | 38.99K | $10.24M | Reduce |
| Q3 2025 | 38.72K | $11.11M | Reduce |
| Q4 2025 | 38.33K | $9.62M | Reduce |
| Q1 2026 | 38.76K | $10.34M | Add |
| Q2 2026 | 39.44K | $11.04M | Add |
| Q3 2026 | 39.65K | $12.22M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LH and 13F data
LH (LABCORP HOLDINGS INC) is a Health Care company. 30 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.35B), Boston Partners (US$854.2M), Allspring Global Investments Holdings, LLC (US$635.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LH
- VICTORY CAPITAL MANAGEMENT INC 4.84M sh · $1.35B · Q2 2026
- Boston Partners 3.05M sh · $854.20M · Q2 2026
- Allspring Global Investments Holdings, LLC 2.24M sh · $635.03M · Q2 2026
- Select Equity Group, L.P. 1.98M sh · $554.95M · Q2 2026
- Navera Investment Management Ltd. 781.73K sh · $218.92M · Q2 2026
- THRIVENT FINANCIAL FOR LUTHERANS 712.30K sh · $199.44M · Q2 2026
- COOKE & BIELER LP 669.18K sh · $187.37M · Q2 2026
More on WEYBOSSET RESEARCH & MANAGEMENT LLC
FAQ
How long has WEYBOSSET RESEARCH & MANAGEMENT LLC held LH?
WEYBOSSET RESEARCH & MANAGEMENT LLC has disclosed LH holdings in 12 of the last 13 reported quarters, going back to Q3 2023.
What is WEYBOSSET RESEARCH & MANAGEMENT LLC's current position in LH?
As of Q3 2026, WEYBOSSET RESEARCH & MANAGEMENT LLC holds 39.65K shares of LH (LABCORP HOLDINGS INC), valued at $12.22M, representing 3.52% of its reported portfolio and ranking #14.
Has WEYBOSSET RESEARCH & MANAGEMENT LLC been buying or selling LH?
In the latest 13F filing (Q3 2026), WEYBOSSET RESEARCH & MANAGEMENT LLC increased its position in LH. The position peaked in Q3 2026 at 39.65K shares.
Which other funds hold LH?
Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.